BESINS Healthcare, manufacturers of Testogel (1% transdermal testosterone gel) estimates that up to 20,000 Australian men may be affected by current shortages of Bayer's Reandron and Primoteston brands.
Besins MD Geoff Blundell has reassured patients and healthcare professionals that Testogel is unaffected by these shortages.
"We are pleased to confirm that wholesalers have access to ample stock of both the Testogel pump and sachet formulations to meet increased need during this period."
Reandron and Primoteston will be unavailable until after 31 Dec 2018 and 31 Mar 2019 respectively.
See tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Oct 18
